Understanding the Effects of Trastuzumab in Oncology
Trastuzumab, a monoclonal antibody, has revolutionized the treatment of HER2-positive breast cancer and other malignancies. Approved by the FDA in 1998, it targets the HER2/neu protein, which promotes the growth of cancer cells. This targeted therapy specifically binds to the HER2 receptor, inhibiting cell proliferation and triggering immune-mediated responses that lead to cancer cell death.For [...]


